TY - JOUR T1 - Causative drugs of Stevens-Johnson syndrome and toxic epidermal necrolysis in Israel. JF - J Clin Pharmacol Y1 - In Press A1 - Maggio, N A1 - Firer, M A1 - Zaid, H A1 - Bederovsky, Y A1 - Aboukaoud, M A1 - Gandelman-Marton, R A1 - Noyman, I A1 - Ekstein, D A1 - Blatt, I A1 - Marom, E A1 - Schwartzberg, E A1 - Israel, S A1 - Ingber, A A1 - Brautbar, C A1 - Eyal, S ER - TY - JOUR T1 - Controlled release of artemisone for the treatment of experimental cerebral malaria. JF - Parasites Vectors Y1 - In Press A1 - Golenser, J. A1 - Buchholz, V A1 - Bagheri, A A1 - Nasereddin, A A1 - Dzikowski, R A1 - Guo, J A1 - Hunt, N A1 - Eyal, S A1 - Vakruk, N A1 - Greiner, A ER - TY - JOUR T1 -

Intraoperative Localization of Rectal Tumors Using Liposomal Indocyanine Green.

JF - Surg Innov Y1 - 2017 A1 - Magdassi, S. A1 - Bar-David, S A1 - Friedman-Levi, Y. A1 - Zigmond, E A1 - Varol, C A1 - Lahat, G A1 - Klausner, J A1 - Eyal, S A1 - Nizri, E. ER - TY - JOUR T1 -

Pharmacokinetics of metoprolol during pregnancy and lactation.

JF - J Clin Pharmacol Y1 - 2016 A1 - Ryu, RJ A1 - Eyal, S A1 - Easterling, TR A1 - Caritis, SN A1 - Venkataraman, R A1 - Hankins, G A1 - Rytting, E A1 - Thummel, K A1 - Kelly, EJ A1 - Risler, L A1 - Phillips, B A1 - Honaker, MT A1 - Shen, DD A1 - Hebert, MF VL - 56 ER - TY - JOUR T1 -

An evaluation of pharmacist knowledge on treatment with antiepileptic drugs.

JF - Seizure Y1 - 2016 A1 - Roth, Y A1 - Neufeld, M A1 - Blatt, I A1 - Guy-Alfandary, S A1 - Rasaby, S A1 - Ekstein, D A1 - Eyal, S VL - 34 ER - TY - JOUR T1 -

Use of antiepileptic drugs during pregnancy and lactation: Type of information provided by searching Google.

JF - Epilepsy Behav Y1 - 2016 A1 - Lavi-Blau, T A1 - Ekstein, D A1 - Neufeld, MY A1 - Eyal, S VL - 55 ER - TY - JOUR T1 -

Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria.

JF - Theranostics Y1 - 2016 A1 - Portnoy, E A1 - Vakruk, N A1 - Bishara, A A1 - Shmuel, M. A1 - Magdassi, S. A1 - Golenser, J. A1 - Eyal, S VL - 6 ER - TY - JOUR T1 -

Tracking inflammation in the epileptic rat brain by bi-functional fluorescent and magnetic nanoparticles.

JF - Nanomedicine Y1 - 2016 A1 - Portnoy, E A1 - Polyak, B A1 - Inbar, D A1 - Kenan, G A1 - Rai, A A1 - Wehrli, SL A1 - Roberts, TP A1 - Bishara, A A1 - Mann, A A1 - Shmuel, M. A1 - Rozovsky, k A1 - Itzhak, G A1 - Ben-Hur, T. A1 - Magdassi, S. A1 - Ekstein, D A1 - Eyal, S VL - 12 ER - TY - JOUR T1 -

Effects of valproic acid on the placental barrier in the pregnant mouse: Optical imaging and transporter expression studies.

JF - Epilepsia Y1 - 2016 A1 - Meir, M A1 - Bishara, A A1 - Mann, A A1 - Udi, S A1 - Portnoy, E A1 - Shmuel, M. A1 - Eyal, S VL - 57 ER - TY - JOUR T1 -

Imaging transporters: Transforming diagnostic and therapeutic development.

JF - Clin Pharmacol Ther Y1 - 2016 A1 - Mann, A A1 - Han, H. A1 - Eyal, S VL - 100 ER - TY - JOUR T1 - Evaluation of near infrared dyes as markers of P-glycoprotein activity in tumors. JF - Frontiers Pharmacol Y1 - 2016 A1 - Semenenko, I A1 - Portnoy, E A1 - Aboukaoud, M A1 - Guzy, S A1 - Shmuel, M. A1 - Itzhak, G A1 - eyal s VL - 7 ER - TY - JOUR T1 - Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations. JF - Epilepsia Y1 - 2016 A1 - Israel, S A1 - Maggio, N A1 - Ekstein, D A1 - Zaid, H A1 - Firer, M A1 - Bederovsky, Y A1 - Noyman, I A1 - Gandelman-Marton, R A1 - Blatt, I A1 - Brautbar, C A1 - Marom E A1 - Nahlieli-Dil, D A1 - Berman, E A1 - Sabag, D A1 - Ingber, A A1 - Eyal, S VL - 57 ER - TY - JOUR T1 - Maternal–fetal transfer of indocyanine green across the perfused human placenta. JF - Reprod Toxicol Y1 - 2016 A1 - Rubinchik-Stern, M A1 - Shmuel, M. A1 - Bar, J A1 - Eyal, S A1 - Kovo, M VL - 62 ER - TY - JOUR T1 - Utilization of antiepileptic drugs in Israel. JF - Epilepsy Behav Y1 - 2016 A1 - Berman, E A1 - Marom, E A1 - Ekstein, D A1 - Blatt, I A1 - Eyal, S VL - 61 ER - TY - JOUR T1 -

Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels.

JF - Epilepsy Behav Y1 - 2015 A1 - Ekstein, D A1 - Tirosh, M A1 - Eyal, Y A1 - Eyal, S VL - 44 ER - TY - JOUR T1 -

Imaging the urinary pathways in mice by liposomal indocyanine green.

JF - Nanomedicine Y1 - 2015 A1 - Portnoy, E A1 - Nizri, E. A1 - Golenser, J. A1 - Shmuel, M. A1 - Magdassi, S. A1 - Eyal, S IS - 11 ER - TY - JOUR T1 -

Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.

JF - AAPS J Y1 - 2015 A1 - Mann, A A1 - Semenenko, I A1 - Meir, M A1 - Eyal, S VL - 17 ER - TY - JOUR T1 -

Antiepileptic drugs alter the expression of placental carriers: An invitro study in a human placental cell line.

JF - Epilepsia Y1 - 2015 A1 - Rubinchik-Stern, M A1 - Shmuel, M. A1 - Eyal, S VL - 56 ER - TY - JOUR T1 -

Near Infrared Imaging of Indocyanine Green Distribution in Pregnant Mice and Effects of Concomitant Medications.

JF - Mol Pharm Y1 - 2015 A1 - Bishara, A A1 - Meir, M A1 - Portnoy, E A1 - Shmuel, M. A1 - Eyal, S VL - 12 ER - TY - JOUR T1 -

Concomitant therapy in people with epilepsy: potential drug-drug interactions and patient awareness.

JF - Epilepsy Behav Y1 - 2014 A1 - Eyal, S A1 - Rasaby, S A1 - Ekstein, D VL - 31 ER - TY - JOUR T1 -

Pharmacokinetics of doxorubicin in pregnant women.

JF - Cancer Chemother Pharmacol Y1 - 2014 A1 - Ryu, RJ A1 - Eyal, S A1 - Kaplan, HG A1 - Akbarzadeh, A A1 - Hays, K A1 - Puhl, K A1 - Easterling, TR A1 - Berg, SL A1 - Scorsone, KA A1 - Feldman, EM A1 - Umans, JG A1 - Miodovnik, M A1 - Hebert, MF VL - 73 ER - TY - JOUR T1 -

Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.

JF - J Nucl Med Y1 - 2014 A1 - Deo, AK A1 - Borson, S A1 - Link, JM A1 - Domino, K A1 - Eary, JF A1 - Ke, B A1 - Richards, TL A1 - Mankoff, DA A1 - Minoshima, S A1 - O'Sullivan, F A1 - Eyal, S A1 - Hsiao, P A1 - Maravilla, K A1 - Unadkat, JD VL - 55 ER - TY - JOUR T1 -

Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging.

JF - Front Pharmacol Y1 - 2014 A1 - Qawasmi, I A1 - Shmuel, M. A1 - Eyal, S VL - 5 ER - TY - JOUR T1 -

The role of aquaporin-1 in idiopathic and drug-induced intracranial hypertension.

JF - Med Hypotheses. Y1 - 2013 A1 - Stiebel-Kalish, H A1 - Eyal, S A1 - Steiner, I VL - 81 ER - TY - JOUR T1 - Drug Interactions at the Human Placenta: What is the Evidence? JF - Front Pharmacol Y1 - 2012 A1 - Rubinchik-Stern, M A1 - Eyal, S VL - 3 ER - TY - JOUR T1 - Evaluation of the near infrared compound indocyanine green as a probe substrate of P-glycoprotein. JF - Mol Pharm Y1 - 2012 A1 - Portnoy, E A1 - Gurina, M A1 - Magdassi, S. A1 - Eyal, S VL - 9 ER - TY - JOUR T1 - Atenolol pharmacokinetics and excretion in breast milk during the first 6 months postpartum. JF - J Clinical Pharmacol Y1 - 2010 A1 - Eyal, S A1 - Kim, JD A1 - Anderson, GD A1 - Buchanan, ML A1 - Brateng, DA A1 - Carr, D A1 - Woodrum, DE A1 - Easterling, TR A1 - Hebert, MF VL - 50 ER - TY - JOUR T1 - CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. JF - Drug Metab Dispos Y1 - 2010 A1 - Claessens, AJ A1 - Risler, LJ A1 - Eyal, S A1 - Shen, DD A1 - Easterling, TR A1 - Hebert, MF VL - 38 ER - TY - JOUR T1 - Pharmacokinetics of metformin during pregnancy. JF - Drug Metab Dispos Y1 - 2010 A1 - Eyal, S A1 - Easterling, TR A1 - Carr, D A1 - Umans, JG A1 - Miodovnik, M A1 - Hankins, JDV A1 - Clark, SM A1 - Risler, L A1 - Wang, J A1 - Kelly, EJ A1 - Shen, DD A1 - Hebert, MF VL - 38 ER - TY - JOUR T1 - Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography. JF - Clin Pharmacol Ther Y1 - 2010 A1 - Eyal, S A1 - Ke, B A1 - Muzi, M A1 - Link, JM A1 - Mankoff, DA A1 - Collier, A A1 - Unadkat, JD VL - 87 ER - TY - JOUR T1 - Drug interactions at the blood-brain barrier: fact or fantasy? JF - Pharmacol Ther Y1 - 2009 A1 - Eyal, S A1 - Hsiao, P A1 - Unadkat, JD VL - 123 ER - TY - JOUR T1 - Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant non-human primate. JF - J Nucl Med Y1 - 2009 A1 - Eyal, S A1 - Chung, F A1 - Muzi, M A1 - Link, JM A1 - Mankoff, DA A1 - Kaddoumi, A A1 - O’Sullivan, F A1 - Hebert, MF A1 - Unadkat, JD VL - 50 ER - TY - JOUR T1 - The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium (TPP). JF - Mol Pharm Y1 - 2009 A1 - Swed, A A1 - Eyal, S A1 - Madar, I A1 - Kontante, H A1 - Weiss, L A1 - Hoffman, A VL - 6 ER - TY - JOUR T1 - Tissue P-glycoprotein activity in the pregnant nonhuman primate changes with gestational age. JF - Br J Pharmacol Y1 - 2009 A1 - Chung, F A1 - Eyal, S A1 - Muzi, M A1 - Link, JM A1 - Mankoff, DA A1 - Kaddoumi, A A1 - Hsiao, P A1 - O’Sullivan, F A1 - Unadkat, JD VL - 159 ER - TY - JOUR T1 - Rapid solid-phase extraction method to quantify [11C]-verapamil, and its [11C]-metabolites, in human and macaque plasma. JF - Nucl Med Biol Y1 - 2008 A1 - Unadkat, JD A1 - Chung, F A1 - Sasongko, L A1 - Whittington, D A1 - Eyal, S A1 - Mankoff, DA A1 - Collier, AC A1 - Muzi, M A1 - Link, J VL - 35 ER - TY - JOUR T1 - The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior. JF - Mol Pharmacol Y1 - 2007 A1 - Shimshoni, JA A1 - Dalton, EC A1 - Jenkins, A A1 - Eyal, S A1 - Ewan, K A1 - Williams, RS A1 - Pessah, N A1 - Yagen B A1 - Harwood, AJ A1 - Bialer, M VL - 71 ER - TY - JOUR T1 - The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver. JF - Br J Pharmacol Y1 - 2006 A1 - Eyal, S A1 - Lamb, JG A1 - Smith-Yockman, M A1 - B. Yagen A1 - E. Fibach A1 - Altschuler, Y A1 - White, HS A1 - Bialer, M VL - 149 ER - TY - JOUR T1 - Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives. JF - Biochem Pharmacol Y1 - 2005 A1 - Eyal, S A1 - B. Yagen A1 - Shimshoni, J A1 - Bialer, M VL - 69 ER - TY - JOUR T1 - Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. JF - Int J Pharm Y1 - 2004 A1 - Hoffman, A A1 - Stepensky, D A1 - Lavi, E A1 - Eyal, S A1 - Klausner, E A1 - Friedman, M VL - 277 ER - TY - JOUR T1 - The activity of antiepileptic drugs as histone deacetylase inhibitors. JF - Epilepsia Y1 - 2004 A1 - Eyal, S A1 - B. Yagen A1 - Sobol, E A1 - Altschuler, Y A1 - Bialer, M VL - 45 ER - TY - JOUR T1 - Novel levodopa gastroretentive dosage form: in vivo evaluation in dogs. JF - J Control Release Y1 - 2003 A1 - Klausner, E A1 - Eyal, S A1 - Lavi, E A1 - Friedman, M A1 - Hoffman, A VL - 88 ER - TY - JOUR T1 - Adverse drug events in hospitalized patients treated vith cardiovascular drugs and anticoagulants JF - Pharmacoepidemiol Drug Saf Y1 - 2002 A1 - Zaidenstein, R A1 - Eyal, S A1 - Efrati, S A1 - Akivison, L A1 - Michowitz, MK A1 - Nagornov, V A1 - Golik, A VL - 11 ER - TY - JOUR T1 - Chronic GnRH administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment. JF - Psychopharmacology Y1 - 2001 A1 - Eyal, S A1 - Weizman, A A1 - Toren, P A1 - Dor, Y A1 - Mester, R A1 - Rehavi, M VL - 125 ER -